Streetbeat News

Stock Prices

CDW

Analysts have provided mixed ratings for CDW (NASDAQ:CDW) over the past quarter, with a majority being bullish. The average 12-month price target has slightly increased to $269.0. CDW's financial performance shows strong net margins and ROE, but faces revenue challenges and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 7:01 pm

EXR

Five analysts have provided mixed opinions on Extra Space Storage (NYSE:EXR) over the past quarter, with most ratings being somewhat bullish. The average 12-month price target has slightly increased to $159.0. Key financial indicators show strong revenue growth and net margin, but a lower return on equity.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 7:00 pm

ETHUSD

Ethereum's price has decreased by 3.98% over the past 24 hours to $3,678.71, continuing a downward trend over the past week. Trading volume has tumbled 10.0% while the circulating supply has risen 1.19%.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 7:00 pm

NVAX

Novavax shares are experiencing a decline after a recent surge in their stock price.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 6:54 pm

DELL

Dell shares are experiencing a pullback after a recent gain.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 6:49 pm

CVNA

Carvana shares are trading higher after JMP Securities maintained a Market Outperform rating and raised its price target from $135 to $150.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 6:45 pm

ARCT

VRTX

Arcturus Therapeutics (NASDAQ:ARCT) presented promising Phase 1 and Phase 1b results for its inhaled mRNA therapeutic, ARCT-032, at the European Cystic Fibrosis Conference. The study showed improvements in lung function in cystic fibrosis patients, with no severe adverse events. Despite a small sample size, the data is encouraging, especially compared to Vertex Pharmaceuticals' (NASDAQ:VRTX) treatments.

Portfolio Pulse from Vandana Singh

June 07, 2024 | 6:44 pm

CTVA

Corteva shares are trading lower following a downgrade from OTR Global, which changed its rating from Mixed to Negative.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 6:44 pm

ACRHF

CGC

Canopy Growth Corporation (NASDAQ:CGC) announced an at-the-market (ATM) equity program to issue and sell up to $250 million worth of its common shares. The program aims to enhance financial flexibility and support strategic initiatives. Despite the positive financial outlook and significant debt reduction, Canopy's stock traded down following the announcement. The company plans to use the proceeds to support existing businesses, fund potential acquisitions, and for general corporate purposes. Additionally, Canopy is advancing its U.S. operations by acquiring Acreage Holdings, Inc. (OTC:ACRHF).

Portfolio Pulse from Javier Hasse

June 07, 2024 | 6:37 pm

IP

International Paper shares are trading higher following a report suggesting Suzano could borrow up to $19 billion for its bid.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 6:32 pm